Eukarya Pharmasite

Monterrey 64718

0 studies enrolling now · 4 studies all time

What they study most

Atopic Dermatitis, Chronic Spontaneous Urticaria, Eczema, Hidradenitis Suppurativa, Obesity, Overweight

Studies at this site

• A Study of Lebrikizumab (LY3650150) in Participants 6 Months to <18 Years of Age With Moderate-to-Severe Atopic Dermatitis — Running, not enrolling
• A Phase 3 Study of Barzolvolimab in Participants With Chronic Spontaneous Urticaria (CSU) — Running, not enrolling
• A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With Obesity — Running, not enrolling
• Lunsayil 1: A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa — Completed